P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

Ting‐Chao Chou · Cancer Research · 2010 · 5.5K citations

Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period

A. J. Norton, J. Matthews, Vasiliki Pappa et al. · Annals of Oncology · 1995 · 177 citations · Full text

Lymphoid Neoplasia, Mantle Cell Lymphoma, 20-Year Period +6

ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances

Emma Camacho, Luís Hernández, Sílvia Hernández et al. · Blood · 2002 · 171 citations · Full text

Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1

M Jourdan, John De Vos, Nadir Mechti et al. · Cell Death and Differentiation · 2000 · 132 citations · Full text

Hematological Malignancy, Cytokine, Bcl-2-family Proteins +7

<i>In vitro</i> antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00

Kalpana Joshi, Maggie J. Rathos, Rajendra Joshi et al. · Molecular Cancer Therapeutics · 2007 · 121 citations · Full text

Chemoprevention Strategy, Retinoblastoma Protein, Cell Cycle +16